News
VisionHealth and Boehringer Ingelheim link up for asthma
Boehringer Ingelheim will cooperate with VisionHealth on improving the use of its ‘Kata’ app, which provides therapy support for asthma and chronic obstructive pulmonary disease (COPD).
You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.
Boehringer Ingelheim will cooperate with VisionHealth on improving the use of its ‘Kata’ app, which provides therapy support for asthma and chronic obstructive pulmonary disease (COPD).